Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma

BACKGROUND: We performed a pilot study using Trojan vaccines in patients with advanced squamous cell carcinoma of the head and neck (SCCHN). These vaccines are composed of HLA-I and HLA-II restricted melanoma antigen E (MAGE)-A3 or human papillomavirus (HPV)-16 derived peptides, joined by furin-clea...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Voskens, Caroline J., Sewell, Duane, Hertzano, Ronna, DeSanto, Jennifer, Rollins, Sandra, Lee, Myounghee, Taylor, Rodney, Wolf, Jeffrey, Suntharalingam, Mohan, Gastman, Brian, Papadimitriou, John C., Lu, Changwan, Tan, Ming, Morales, Robert, Cullen, Kevin, Celis, Esteban, Mann, Dean, Strome, Scott E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3725741/
https://ncbi.nlm.nih.gov/pubmed/22287423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.22004
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg